Research Article
You have full text access to this OnlineOpen article
A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications
Article first published online: 28 JUL 2005
DOI: 10.1002/art.21191
Copyright © 2005 by the American College of Rheumatology
Additional Information
How to Cite
Holman, A. J. and Myers, R. R. (2005), A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis & Rheumatism, 52: 2495–2505. doi: 10.1002/art.21191
Publication History
- Issue published online: 28 JUL 2005
- Article first published online: 28 JUL 2005
- Manuscript Accepted: 19 APR 2005
- Manuscript Received: 20 DEC 2004
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , Structural changes of the brain in rheumatoid arthritis, Arthritis & Rheumatism, 2012, 64, 2Direct Link:
- 2, , The Role of Antipsychotics in the Management of Fibromyalgia, CNS Drugs, 2012, 26, 2, 135
- 3, , , , A Meta-Analysis of Pain Response in the Treatment of Fibromyalgia, Pain Practice, 2011, 11, 6Direct Link:
- 4, , , , , , A Systematic Review and Mixed Treatment Comparison of the Efficacy of Pharmacological Treatments for Fibromyalgia, Seminars in Arthritis and Rheumatism, 2011, 41, 3, 335
- 5
- 6, Acute and Chronic Pain Management in Fibromyalgia: Updates on Pharmacotherapy, American Journal of Therapeutics, 2011, 18, 6, 487
- 7, , Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists, Expert Opinion on Pharmacotherapy, 2011, 12, 9, 1381
- 8, , Fibromyalgia: from pathophysiology to therapy, Nature Reviews Rheumatology, 2011, 7, 9, 518
- 9, , , , Fibromyalgie et psychiatrie : 35 ans plus tard⦠Quoi de neuf ?, La Presse Médicale, 2011,
- 10, , , , , , , , , , High frequency of childhood ADHD history in women with fibromyalgia, European Psychiatry, 2011, 26, 8, 482
- 11, , , Neoteric pharmacotherapeutic targets in fibromyalgia, Expert Opinion on Therapeutic Targets, 2011, 15, 11, 1267
- 12
- 13, , , New Concepts in Pain Research and Pain Management of the Rheumatic Diseases, Seminars in Arthritis and Rheumatism, 2011, 41, 3, 319
- 14, , , Pharmacotherapy of fibromyalgia, Best Practice & Research Clinical Rheumatology, 2011, 25, 2, 285
- 15, , , , , , , , , , , , , , , , Pramipexole Reduces the Prevalence of Fatigue in Patients with Parkinson's Disease, Internal Medicine, 2011, 50, 19, 2163
- 16
- 17
- 18, , , Targeting fibromyalgia pain: brainâspinal cord and peripheral contributions, International Journal of Clinical Rheumatology, 2011, 6, 4, 463
- 19, , , The use of opioids in fibromyalgia, International Journal of Rheumatic Diseases, 2011, 14, 1Direct Link:
- 20, Tratamiento farmacológico en la fibromialgia, Seminarios de la Fundación Española de ReumatologÃa, 2011, 12, 1, 21
- 21
- 22, , , , , , , , , , , , , Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: Results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study, Arthritis & Rheumatism, 2010, 62, 1Direct Link:
- 23
- 24, , Rational treatment of fibromyalgia for a solo practitioner, Best Practice & Research Clinical Rheumatology, 2010, 24, 3, 341
- 25
- 26, , , , Why do some promising brain-stimulation devices fail the next steps of clinical development?, Expert Review of Medical Devices, 2010, 7, 1, 67
- 27, , A symptom-based approach to pharmacologic management of fibromyalgia, Nature Reviews Rheumatology, 2009, 5, 4, 191
- 28, , , , , , , , , , , Altered amino acid homeostasis in subjects affected by fibromyalgia, Clinical Biochemistry, 2009, 42, 10-11, 1064
- 29, Assessing patients with fibromyalgia from a rheumatologistâs perspective: a three-step methodology for differential diagnosis, International Journal of Clinical Rheumatology, 2009, 4, 4, 409
- 30, , , , , , , Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans, PAIN, 2009, 147, 1-3, 187
- 31, , , , Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia, PAIN, 2009, 146, 1-2, 26
- 32
- 33, Fibromyalgia—pathways and neurotransmitters, Human Psychopharmacology: Clinical and Experimental, 2009, 24, S1Direct Link:
- 34, , Fibromyalgia: a complex syndrome requiring a multidisciplinary approach, Human Psychopharmacology: Clinical and Experimental, 2009, 24, S1Direct Link:
- 35, , Fibromyalgia: current diagnosis and management, Expert Review of Clinical Immunology, 2009, 5, 2, 181
- 36
- 37, , , Human evidence of a supra-spinal modulating role of dopamine on pain perception, Synapse, 2009, 63, 5Direct Link:
- 38, Impulse Control Disorder Behaviors Associated with Pramipexole Used to Treat Fibromyalgia, Journal of Gambling Studies, 2009, 25, 3, 425
- 39, , , , , , , , , Intravenous Micronutrient Therapy (Myers' Cocktail) for Fibromyalgia: A Placebo-Controlled Pilot Study, The Journal of Alternative and Complementary Medicine, 2009, 15, 3, 247
- 40, , Pharmacotherapy of Fibromyalgia, Rheumatic Disease Clinics of North America, 2009, 35, 2, 359
- 41, Pregabalin as treatment for fibromyalgia: The rest of the story?, Current Pain and Headache Reports, 2009, 13, 6, 420
- 42, The Significance of Dysfunctions of the Sleeping/Waking Brain to the Pathogenesis and Treatment of Fibromyalgia Syndrome, Rheumatic Disease Clinics of North America, 2009, 35, 2, 275
- 43, , Understanding Fibromyalgia: Lessons from the Broader Pain Research Community, The Journal of Pain, 2009, 10, 8, 777
- 44
- 45, Central Sensitivity Syndromes: A New Paradigm and Group Nosology for Fibromyalgia and Overlapping Conditions, and the Related Issue of Disease versus Illness, Seminars in Arthritis and Rheumatism, 2008, 37, 6, 339
- 46, , Dopamine et douleur : une revue de littérature, Douleur et Analgésie, 2008, 20, 4, 246
- 47, , , , , , , , , Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial, PAIN, 2008, 136, 3, 432
- 48
- 49, , , , , Factors affecting self-efficacy and pain intensity in patients with chronic musculoskeletal pain seen in a specialist rheumatology pain clinic, Rheumatology, 2008, 47, 12, 1803
- 50, , , , , Fibromyalgia: Combining Pharmacological and Nonpharmacological Approaches to Treating the Person, Not Just the Pain, The Journal of Pain, 2008, 9, 2, 99
- 51, , , , , , Fibromyalgia: Nosography and Therapeutic Perspectives, Pain Practice, 2008, 8, 3Direct Link:
- 52, , Fibromyalgia: Should the treatment paradigm be monotherapy or combination pharmacotherapy?, Current Pain and Headache Reports, 2008, 12, 6, 399
- 53, , Fibromyalgie : exemple dâinteractions entre sommeil et douleur, Douleur et Analgésie, 2008, 20, 4, 239
- 54, , Interventions pharmacologiques chez le patient fibromyalgique : par où commencer ?, Douleur et Analgésie, 2008, 20, 4, 227
- 55
- 56, , , , , , , , , , , , Medikamentöse Therapie des Fibromyalgiesyndroms, Der Schmerz, 2008, 22, 3, 313
- 57, , , , Nabilone for the Treatment of Pain in Fibromyalgia, The Journal of Pain, 2008, 9, 2, 164
- 58
- 59, Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies?, Drug Discovery Today, 2008, 13, 7-8, 333
- 60, Positional Cervical Spinal Cord Compression and Fibromyalgia: A Novel Comorbidity With Important Diagnostic and Treatment Implications, The Journal of Pain, 2008, 9, 7, 613
- 61, Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia, Current Pain and Headache Reports, 2008, 12, 6, 393
- 62
- 63, Role of central dopamine in pain and analgesia, Expert Review of Neurotherapeutics, 2008, 8, 5, 781
- 64, The significance of the sleepingâwaking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes, Joint Bone Spine, 2008, 75, 4, 397
- 65, , , , , Treatment Strategy in Fibromyalgia Syndrome: Where Are We Now?, Seminars in Arthritis and Rheumatism, 2008, 37, 6, 353
- 66, , , , Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition interaction, Brain, 2008, 131, 12, 3222
- 67, Are complex therapies required as pharmacological treatments of fibromyalgia?, Future Rheumatology, 2007, 2, 6, 599
- 68, Fibromyalgia and Overlapping Disorders: The Unifying Concept of Central Sensitivity Syndromes, Seminars in Arthritis and Rheumatism, 2007, 36, 6, 339
- 69
- 70, , Fibromyalgia: 30 years of drug-seeking behavior, Nature Clinical Practice Rheumatology, 2007, 3, 2, 62
- 71, Fibromyalgia: Update on Mechanisms and Management, JCR: Journal of Clinical Rheumatology, 2007, 13, 2, 102
- 72
- 73, , , Novel pharmacotherapy for fibromyalgia, Expert Opinion on Investigational Drugs, 2007, 16, 6, 829
- 74, , , , , Parkinson disease patient with fibromyalgia: A case report, Parkinsonism & Related Disorders, 2007, 13, 5, 312
- 75, Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain, Best Practice & Research Clinical Rheumatology, 2007, 21, 3, 499
- 76, Psychopharmakotherapie somatoformer Störungen und funktioneller somatischer Syndrome, Psychiatrie und Psychotherapie, 2007, 3, 4, 153
- 77, , , , , , Reduced Presynaptic Dopamine Activity in Fibromyalgia Syndrome Demonstrated With Positron Emission Tomography: A Pilot Study, The Journal of Pain, 2007, 8, 1, 51
- 78, , , , , , , Striatal grey matter increase in patients suffering from fibromyalgia â A voxel-based morphometry study, PAIN, 2007, 132, S109
- 79, , , , , , , The effects of multidisciplinary therapy on positron emission tomography of the brain in fibromyalgia: a pilot study, Rheumatology International, 2007, 27, 11, 1019
- 80, Treatment of fibromyalgia and its symptoms, Expert Opinion on Pharmacotherapy, 2007, 8, 11, 1629
- 81, A Reconsideration of the Relevance of Systemic Low-Dose Ketamine to the Pathophysiology of Fibromyalgia, The Journal of Pain, 2006, 7, 9, 611
- 82, , , Mechanisms of Disease: genetics of fibromyalgia, Nature Clinical Practice Rheumatology, 2006, 2, 12, 671
- 83, , , , Otras opciones terapéuticas en la fibromialgia, Medicina ClÃnica, 2006, 127, 2, 76
- 84, , Therapy Insight: fibromyalgiaâa different type of pain needing a different type of treatment, Nature Clinical Practice Rheumatology, 2006, 2, 7, 364
- 85, , Fibromyalgia: Progress in diagnosis and treatment, Current Pain and Headache Reports, 2005, 9, 6, 399
- 86
- 87, , Pain and Paresthesia in Parkinson's Disease,Direct Link:

1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
1529-0131/asset/cover.gif?v=1&s=104d5c2bb8ef72deba26790b855af7ab80697a0e)